US 155mm Artillery Production Capacity Shortfall and Munitions Industrial Mobilization Constraints

Executive Summary

The Pentagon's own watchdog has confirmed what our July 15 analysis characterized as a manufacturing execution deficit: as of March 2026, the US Army was producing only 36,000 155mm rounds per month against a target of 100,000, leaving it at 36% of goal nearly nine months after the original deadline passed. The failure is not monolithic, it is a three-layer stack: forged steel projectile bodies are the rate-limiting constraint identified by the DoD Inspector General, propellant supply is a concurrent and independent chokepoint documented by the Radford expansion schedule, and load-assemble-pack capacity, while improving after Camden, Arkansas came online, cannot exceed what the front-end forging base delivers. On July 15, President Trump announced $10 billion in defense investment commitments from roughly 40 companies at the Pennsylvania Defense and Innovation Summit, with munitions explicitly named as a priority. The capital signal is real; the production impact is not. None of the Summit commitments will yield shells before 2027 at the earliest.

• Defense industrial base procurement officers: The IG's finding that the Army Contracting Command did not open the Mesquite contract to competition is now a documented contractual risk; flag sole-source ammunition contracts across your portfolio for auditor review before FY27 appropriations.
• Risk officers holding positions in Raytheon, General Dynamics, and BAE Systems: The $10 billion Pennsylvania announcement sustains near-term backlog valuations but does not compress the stockpile gap timeline; do not price in volume upside before Q1 2028.
• Policy stakeholders advising on NATO allied demand: The 36,000 rounds/month figure is the shared pool from which US training, Foreign Military Sales, and allied resupply all draw; allied demand is not additive to a domestic stockpile, it competes directly with it.

The production deficit is structural, not cyclical, and no announced investment is sized or sequenced to close the gap before December 2027 at the earliest.

The Three-Layer Constraint Stack

The failure of US producers to meet the 100,000 shell target cannot be understood as a single problem. The IG's July 9 report identifies projectile metal part production as the primary rate limiter, confirming that the entire production system is front-end constrained. Before a shell is packed with explosives at a load-assemble-pack facility, a 2,000-pound steel bar must be forged, machined, heat-treated, and inspected to specification at a metal parts plant. The Scranton Army Ammunition Plant, operated by General Dynamics under contract since 2006, was the sole such facility until 2024. The Army addressed this single-source risk by constructing Mesquite as an automated, Turkish-equipment-based facility designed to deliver 30,000 additional parts per month. The decision to adapt older equipment to produce newer-model projectile rounds, flagged by Stars and Stripes as the root technical cause, produced the zero-output failure documented in the IG report.

The second layer is propellant. Producing a complete 155mm round requires approximately 21 pounds of smokeless powder, the primary ingredient of which is nitrocellulose, as documented by Homeland Arms in March 2026. The global nitrocellulose supply chain, which runs through a small number of producers globally, has been under sustained demand pressure since 2022. The Radford Army Ammunition Plant in Virginia is the site of the Army's primary domestic nitrocellulose investment, and the Army opened new propellant charge facilities in Marion, Illinois and Perry, Florida in October 2024, ahead of schedule. However, the Joint Energetics Transition Office, designed to coordinate the entire energetics supply chain, was still in early organizational stages as of mid-2026 according to Defense Security Monitor. This coordination gap means the propellant buildup is proceeding on a separate schedule from the projectile buildup, and neither is keyed to a common production synchronization plan.

The third layer is load-assemble-pack capacity. Here, the picture is materially better. The Camden LAP facility opened April 2025 and is expected to supply half of the 100,000 target capacity. Iowa Army Ammunition Plant is being modernized. Parsons, Kansas, is planned. The Army awarded more than $800 million in multi-year contracts to support this expansion per Defense Security Monitor. The irony documented in the IG report is precise: the Army has built downstream capacity that exceeds its upstream supply. The LAP facilities in Camden and Iowa can load more shells than Scranton and the defunct Mesquite plant can supply. That downstream investment is stranded until the projectile body constraint is resolved.

What is not being reported: public coverage of the $10 billion Pennsylvania announcement consistently frames the investment as a munitions capacity solution. The Summit's 30-plus announcements, per the Department of War's readout, span AI, robotics, shipbuilding, and space alongside munitions. The munitions-specific allocation within that figure is not publicly disaggregated, and the timeline for conversion of capital into qualified production capacity has not been specified in any official document reviewed for this assessment.

Contractual Failure And The Competitive Sourcing Gap

The Mesquite failure is not purely a technical problem. The IG report surfaced a procurement process concern that has strategic implications: Army officials expressed concern to the IG's evaluation team that the Army Contracting Command did not open the Mesquite facility contract to competition. General Dynamics Ordnance and Tactical Systems received a sole-source award and then operated a facility that produced zero qualifying subcomponents over a period of at least 18 months while drawing $469 million in Army investment.

The Assistant Secretary of the Army for Acquisition, Sustainment, and Technology, Brent Ingraham, told lawmakers in February 2026 that he was "not happy" with Mesquite's performance, per Breaking Defense. That posture, clearly stated to Congress months before the IG report, did not produce a replacement plan. As of March 2026, the IG found that Army Capability Program Executive officials had not developed a plan to produce the additional rounds that were supposed to come from Mesquite. This contractual and planning failure compounds the technical one, because the 18-24 months required to qualify a new contractor and stand up replacement capacity cannot begin until that replacement decision is made.

This constraint translates directly into industrial base financial risk. Companies with exposure to the munitions prime contractor tier, specifically General Dynamics, which operates both Mesquite and Scranton, face a dual-dynamic: continued demand for Scranton output sustains revenue, while Mesquite's under-performance creates contract review risk. The IG recommended the Army review whether the Mesquite contract was appropriately issued and whether the Department could recoup any funds. Contract claw-back proceedings, if initiated, would be the first observable signal that the Army is shifting its procurement posture.

Counterfactual: what would have happened without Mesquite: the Army's three existing facilities in Scranton, Wilkes-Barre, and Ingersoll, Canada, were producing approximately 36,000 rounds per month before Mesquite was supposed to contribute its 30,000. The counterfactual is that the Army would have reached 36,000 regardless of the $469 million Mesquite investment, since that is precisely where output stands today. The opportunity cost identified by the IG, that the $469 million could have addressed other Army or DoD priorities, is therefore not hypothetical; it is the operational reality.

Allied Demand Competition And The Americas Scenario

The US 155mm shell is the NATO field artillery round, used in the M777 howitzer and M109 Paladin and fielded by allied forces across Europe and the Indo-Pacific. The DoD IG confirmed a total drawdown exceeding 3.6 million rounds from US stocks since 2022, with over 3 million delivered to Ukraine. A further 329,494 rounds went to US training and Foreign Military Sales customers. These figures establish that US shell production is not rebuilding a stockpile toward a floor; it is the primary resupply mechanism for a pool that is simultaneously being drawn down by three categories of demand.

A high-intensity conflict scenario in the Western Hemisphere, involving peer or near-peer adversary engagement with sustained artillery exchange, would draw from a production base currently outputting 36,000 rounds per month. Historical analysis of high-intensity conventional warfare, drawing on the Congressional Research Service's documented consumption rates for Ukraine-scale operations, suggests that a well-equipped force can expend 10,000-20,000 rounds per day in sustained operations. At 36,000 per month, total US production is equivalent to two to four days of high-intensity consumption. This framing is not presented as a probability assessment of any specific conflict; it is a stock-versus-flow calibration that decision-makers evaluating Western Hemisphere risk must incorporate.

Coalition fracture point: the allied ammunition demand picture is not unified. Ukraine, South Korea, and Japan are each acquiring 155mm shells through different mechanisms, some domestically, some through US FMS, some through European producers. Day & Zimmermann reported an all-time production high of nearly 45,000 M795 rounds in March per National Defense Magazine, an achievement that reflects genuine private-sector acceleration. However, M795 production at one company does not substitute for the Mesquite 30,000-part-per-month gap in projectile bodies, because M795 production at Wilkes-Barre requires projectile metal parts that flow through the same constrained supply chain.

The broader geopolitical and economic implications compound directly: if the US curtails Ukraine shell deliveries to replenish Western Hemisphere operational reserves, allied confidence in US security commitments suffers a measurable reputational cost. If it does not curtail deliveries, US operational reserve remains below the floor established in the 2025 National Defense Industrialization Strategy. Both options carry costs; neither is resolved by the $10 billion Pennsylvania announcement on a timeline relevant to a 2026-2027 contingency window.

Counterarguments

1. The production gap may close faster than modeled because Day and Zimmermann's March milestone shows private-sector acceleration that the IG's March figure does not fully capture. National Defense Magazine documented Day and Zimmermann's record output of nearly 45,000 M795 rounds in March 2025, predating the IG's March 2026 snapshot. If multiple private producers have reached similar milestones and if the Scranton expansion's three new production lines have come online on schedule, total output could be higher than 36,000 as of July 2026. The IG's March figure may represent a floor, not a ceiling. This assessment would require revision if the Army's Program Executive Office for Ammunition and Armaments publishes a Q2 2026 production update showing output materially above 36,000.

2. The nitrocellulose and propellant bottleneck may be less binding than the Homeland Arms and Defense Security Monitor reporting suggests, because the Camden and Marion facilities represent domestic propellant capacity that was not yet counted in earlier assessments. The National Defense Magazine report from August 2025 documented that propellant charge production lines in Marion, Illinois, and Perry, Florida, opened two months ahead of schedule in October 2024. If those lines have ramped as designed, propellant may no longer be the binding constraint, leaving projectile bodies as the sole critical path item. This counterargument materially weakens the two-independent-bottleneck framing if confirmed.

3. The sole-source contract critique underweights the degree to which Turkey's proprietary production system was genuinely the fastest path to 30,000 additional projectile parts per month in 2023-2024. The Army's October 2024 Defense News reporting confirmed it contracted Turkish production equipment for Mesquite because it represented the fastest known path to automated projectile production at scale. If no qualified US alternative existed in 2023, the sole-source decision may have been the correct risk trade, even if the outcome was failure. The IG's recommended review of the contract award is appropriate; the conclusion that the award was wrong may not follow from the same evidence.

Indicators To Watch

Near-term watch list: (1) Army PEO A&E production briefing to Congress, expected in September-October 2026 in connection with FY27 NDAA authorization markups, the first public opportunity to see whether March's 36,000 has moved; (2) JETO's initial implementation plan, required under the FY24 NDAA with no hard delivery date established, which when published will indicate whether energetics are being managed as a coordinated program or as individual plant investments; (3) DoD Inspector General follow-up on the Mesquite contract review recommendation, which if accepted triggers an Army Contracting Command timeline that should produce a public notice within 60-90 days.

Decision Relevance

Scenario A (~55%): Partial recovery to 50,000-65,000 rounds per month by mid-2027, as Scranton expansion lines reach operational status and propellant facilities ramp, but Mesquite remains a zero-output liability. Our July 15 assessment placed prolonged partial replenishment at ~55% and that estimate holds; the production band is now more precisely characterized. If you hold positions in General Dynamics as a munitions prime contractor, the Scranton revenue stream is intact and expanding, but watch for Mesquite contract review proceedings as a downside catalyst, since a claw-back demand or contract termination would appear as a one-time charge against the ordnance segment. If you advise on NATO resupply policy, this scenario means the allied demand queue and domestic stockpile replenishment remain in direct competition through 2028; prioritization must be made explicit in FY27 security assistance legislation rather than managed informally.

Scenario B (~25%): Congressional supplemental of $10 billion or more for munitions production capital passes in Q4 2026, accelerating qualified facility standup and driving output above 80,000 rounds per month before end of 2027. Our July 15 assessment put this at ~30%; it is revised slightly downward because the Pennsylvania Summit's $10 billion is private capital, not congressional appropriation, and the two funding streams move on different timelines for very different outcomes. If you are an investor in defense-adjacent precision manufacturing, this scenario's materialization hinges on a single observable: whether the FY27 NDAA markup includes a dedicated munitions capital account above $8 billion. If you are evaluating entry into the defense manufacturing sector as an Anduril-type non-traditional entrant, this scenario is the entry window; begin pre-qualification engagement with Joint Munitions Command now so you can act within 30 days of an appropriation.

Scenario C (~20%): Mesquite is formally terminated, a replacement contractor is identified under an expedited qualification process, and output reaches 90,000 rounds per month by late 2027. This is a more optimistic variant than our prior coverage assumed possible. The IG's explicit recommendation for contract review creates a legal pathway for Army action that did not exist with the same clarity before July 9. If you advise on defense procurement policy and have standing before the Army Contracting Command, this scenario benefits from early engagement with the Army's Program Executive Office on alternative projectile sources, since the competition process that the IG implicitly endorsed has not yet been initiated.

• The 36,000 rounds per month figure is the most recent publicly confirmed data point, drawn from the DoD Inspector General's March 2026 snapshot. Output in April through July 2026 is not publicly available; actual current production may be higher or lower, and this assessment would require revision if the Army publishes a mid-year production update before the September Congressional briefing cycle.
• The propellant bottleneck characterization rests primarily on industry trade reporting and the IG's disclosure of the 66,000-ton explosives requirement. Classified assessments of Radford and Holston output rates, which are not in the public record, would materially change the severity of the propellant constraint if those facilities are performing above publicly disclosed capacity.
• Allied demand competition is assessed qualitatively. Classified FMS pipeline data and NATO combined munitions requirements would allow a quantified competition model; absent that data, the competition framing is correct in direction but imprecise in magnitude.
• The $10 billion Pennsylvania Summit investment figure encompasses munitions, shipbuilding, space, AI, and robotics. No disaggregated munitions-specific allocation was publicly released, so the munitions-relevant portion of the commitment is unknown and may be materially smaller than the headline figure suggests.

Expert Integration

Expert Consensus Assessment

Government, trade press, and independent defense industry analysts drawing on the DoD Inspector General's primary evaluation, Army Program Executive Office disclosures, and Breaking Defense's primary reporting largely agree that the production gap is real, the Mesquite failure is documented, and the December 2027 140,000-round goal is aspirational without a replacement plan for Mesquite's intended 30,000-part contribution. There is less consensus on whether the propellant bottleneck is independently binding or whether the Marion and Perry facilities have reduced it to a secondary constraint.

Expert Disagreement Areas

• Severity of propellant constraint: National Defense Magazine's industry-sourced reporting (August 2025) suggested propellant facilities opened ahead of schedule, while Defense Security Monitor's June 2026 analysis characterized energetics coordination as still fragmented. The IG's primary report focuses on projectile metal parts as the limiting factor without quantifying propellant independently.
• Timeline to replacement sourcing: Breaking Defense (February 2026) and Stars and Stripes (July 2026) both document Army frustration with GD-OTS, but no analyst has publicly specified whether a qualified replacement source for Mesquite's production mission exists in the US industrial base or whether the Army would need to pursue allied sourcing.

Systematic-Expert Alignment

Alignment: ALIGNED

This assessment's core finding, that the production gap is structural and not cyclical, aligns with the IG's documented findings and with the consensus of defense trade reporting. The two-bottleneck framing (projectile body plus propellant) is a synthesis not explicitly stated in any single source but is supported by the cumulative evidence across the IG report, Defense Security Monitor, Homeland Arms, and Defense . Analysts should treat the propellant conclusion as a reasonable inference requiring confirmation from JETO's first operational report.